China has proposed new export controls covering 40 advanced technologies across artificial intelligence (AI), solar energy and biotechnology, signalling a stronger effort to regulate the overseas transfer of strategically important technical knowledge. Announced on October 16, 2026, by China’s Ministry of Commerce and Ministry of Science and Technology, the draft revision proposes outright export prohibitions for 14 technologies and restrictions requiring approval for another 26. The proposal is open for public consultation until November 15, 2026.
The measures could affect international technology partnerships, AI development, next-generation solar manufacturing and selected biotechnology platforms. However, they do not amount to a blanket ban on Chinese AI services, solar panels or biotech products. The draft focuses on specified technologies and technical transfers, with exemptions for much publicly available technology. For India, the proposed restrictions could create additional challenges for companies seeking Chinese manufacturing know-how as the country expands its domestic solar supply chain.
Key Takeaways
- 40 technologies targeted: China’s draft covers AI, photovoltaic solar technology and biotechnology.
- 14 proposed export bans: These technologies would be prohibited from export under the draft.
- 26 proposed restrictions: Transfers involving these technologies would require the applicable permissions.
- AI controls: The list covers 23 AI technologies, including foundation models, intelligent agents and computing clusters.
- Solar controls: The proposal targets selected manufacturing technologies for advanced solar cells, modules and polysilicon.
- Biotechnology: Certain cell and gene therapy platforms and related technologies are included.
- Consultation deadline: Public comments are open until November 15, 2026.
- Important distinction: Most AI technologies and most solar exports would remain outside the proposed controls.
What Has China Proposed?
China’s Ministry of Commerce and Ministry of Science and Technology have proposed revising the country’s Catalogue of Technologies Prohibited or Restricted from Export. The catalogue determines which technical capabilities Chinese entities may transfer overseas and which require additional regulatory permission.
The October 16 announcement, identified as Announcement No. 48 of 2026, covers 40 technologies across three industries.
| Sector | Technologies covered in the proposal |
|---|---|
| Artificial intelligence | 23 |
| Photovoltaics and solar energy | 12 |
| Biotechnology | 5 |
| Total | 40 |
Of the 40 technologies, 14 would be prohibited from export, while 26 would be subject to restrictions. A restricted technology may still be transferred overseas if the applicable licensing requirements are satisfied; a prohibited technology would face a ban under the proposed rules.
The distinction is important for companies with international operations. A technology restriction does not necessarily prevent a business from selling a finished product abroad. It can instead limit the transfer of manufacturing processes, technical knowledge, intellectual property or other specified capabilities used to develop that product.
The proposal remains subject to consultation and final regulatory decisions. Companies should therefore distinguish the draft measures from the final rules that may eventually take effect.
Why Is China Tightening Technology Export Controls?
China’s stated rationale centres on national security, the protection of strategically important technology and the prevention of misuse. The authorities argue that advances in AI, biotechnology and solar manufacturing have increased the sensitivity of technologies that can be transferred internationally.
These industries have become increasingly important to economic competitiveness and national security. AI systems can support industrial automation, research and cybersecurity, but certain capabilities can also be misused to generate malicious software or target critical infrastructure. Biotechnology can produce medical advances while raising concerns about sensitive biological research. Solar manufacturing technologies are relevant to energy security and industrial competitiveness.
China’s proposal also comes amid wider restrictions on technology transfers between major economies, particularly in advanced computing and semiconductors. The United States has imposed controls affecting China’s access to certain advanced chips and related technologies. Beijing’s proposed measures add another dimension to the international debate over how countries regulate strategically important technology.
However, the proposal should not be interpreted as proof that every restriction is a direct response to a particular US measure. China’s technology export catalogue is an established regulatory framework, and the authorities have presented the current revision as part of that process.
AI Export Controls Could Affect Models and Intelligent Agents
Artificial intelligence accounts for 23 of the 40 technologies covered by the proposal. The list includes areas involving foundation models, intelligent agents, computing clusters and information-processing technologies.
Foundation models are large AI systems that can be adapted to perform multiple tasks, including writing, programming, analysis and image processing. AI agents build on model capabilities to carry out sequences of actions, potentially interacting with software and external tools to complete tasks.
Computing clusters are also important because advanced AI development requires coordinated computing resources. Technical knowledge related to these systems can affect how efficiently companies train models, deploy them and operate them at scale.
One stated concern involves technologies that can autonomously generate or modify malicious code. Such capabilities could be used to target government networks, defence systems or critical infrastructure. China’s authorities say controls are intended to reduce the risks associated with transferring sensitive technology to parties that could misuse it.
Will China ban all AI exports?
No. The proposal does not prohibit every Chinese AI model, application or service from being used overseas.
Chinese AI companies have expanded internationally through applications, websites, software-as-a-service products and application programming interfaces (APIs). Under the proposed framework described by Reuters, access through these channels would remain outside the specified restrictions, even where the underlying technology is sensitive, subject to the final rules.
This distinction could allow companies such as DeepSeek and Alibaba to continue serving international users while facing additional scrutiny over certain transfers of underlying technology.
The draft also generally exempts technologies already in the public domain through open-source releases or academic publications. Open-source projects and some overseas computing activities may qualify for facilitation measures.
These provisions mean that the proposal is focused on controlling specified technology transfers rather than shutting down China’s AI industry or ending all international access to Chinese AI services.
Solar Manufacturing Technology Faces New Restrictions
The solar-energy provisions could have significant implications for countries seeking to develop more advanced domestic manufacturing capabilities.
China has become a major supplier across the global solar manufacturing chain, including polysilicon production, wafers, solar cells and finished modules. Its industrial scale and technical expertise have helped shape the economics of solar deployment worldwide.
The proposed controls cover 12 photovoltaic technologies, including selected methods used in polysilicon production, wafer manufacturing and solar-cell production.
Some next-generation solar technologies, including specified perovskite and tandem solar-cell and module manufacturing processes, are proposed for outright export prohibition. Certain polysilicon engineering technologies for production lines with annual capacity of at least 30,000 tonnes would be subject to restrictions.
| Solar technology area | Proposed treatment |
|---|---|
| Certain perovskite and tandem cell and module manufacturing technologies | Export prohibition proposed |
| Selected polysilicon engineering technology for large production lines | Restricted export proposed |
| Selected wafer and solar-cell manufacturing technologies | Subject to the proposed catalogue provisions |
| Most other solar exports | Not covered by a blanket ban |
The measures concern specified technical capabilities, not all solar panels or all equipment associated with solar power. Their actual effect will depend on the precise scope of the final catalogue, licensing decisions and the technologies involved in individual transactions.
Why next-generation solar technology matters
Perovskite solar cells and tandem cells are being developed to improve solar-conversion efficiency. Tandem designs combine different types of photovoltaic materials so that they can capture more of the energy in sunlight than a single-junction cell under suitable conditions.
Manufacturing these technologies at commercial scale requires specialised knowledge about materials, processing, production equipment and quality control. Restricting the export of certain manufacturing methods could make it harder for overseas businesses to acquire those capabilities from Chinese suppliers.
The immediate consequences would not necessarily be visible in retail solar-panel prices. The more direct concern is access to advanced production know-how, particularly for companies planning to build manufacturing capacity outside China.
What the Proposal Could Mean for India
India has been attempting to reduce its dependence on imported solar manufacturing inputs and develop a more integrated domestic supply chain. Government incentives, including the Production Linked Incentive scheme for high-efficiency solar photovoltaic modules, are intended to encourage investment in local manufacturing.
The proposed Chinese restrictions could complicate that effort if Indian companies need access to particular manufacturing processes or technical expertise covered by the catalogue.
For example, a company planning to establish an advanced solar-cell factory might require foreign technical assistance, process licensing or a transfer of specialised production knowledge. If the relevant technology is prohibited from export, the company may need to develop an alternative process. If the technology is restricted, the transfer could depend on obtaining the necessary permission.
The impact would vary by technology and project. Indian manufacturers may already possess some capabilities, source equipment from multiple countries or develop partnerships with other technology providers. The proposal therefore does not establish that India’s entire solar expansion programme will be delayed.
Nevertheless, it reinforces a strategic challenge for India: increasing manufacturing capacity is not only about building factories. It also requires access to technology, specialised equipment, skilled workers and the knowledge needed to operate production lines efficiently.
Biotechnology Controls Add Another Layer
The draft also includes five technologies in biotechnology. The proposed measures cover certain platforms related to cell and gene therapies and technologies involving small interfering RNA, commonly known as siRNA.
Cell and gene therapies are designed to treat diseases by modifying, replacing or using cells and genetic material in therapeutic approaches. siRNA technology can influence gene expression by targeting specific RNA molecules. Both areas are important in advanced medical research and drug development.
The proposal includes restrictions on transfers of intellectual property ownership involving certain novel cell and gene therapy technologies and siRNA-related capabilities. The exact implications will depend on the technologies listed and the final regulatory language.
For biotechnology companies, technology transfers and intellectual property agreements are important for international research partnerships, licensing arrangements and commercial development. Additional approval requirements could create more compliance work or affect the timing of some transactions.
However, the proposed measures do not amount to a general prohibition on international pharmaceutical trade or the export of all medicines developed in China. They target specified technologies and transfers rather than every product in the biotechnology sector.
What Businesses Should Watch Next
Companies with Chinese technology partnerships will need to examine the proposed catalogue carefully to determine whether their activities could fall within the restrictions.
The first milestone is the November 15, 2026, deadline for public consultation. The authorities may revise the draft before issuing final rules, so businesses should not assume that every provision will remain unchanged.
Exporters are also being required to register certain overseas technology transfers under temporary measures that took effect on October 16, pending the final rules. The reported requirement covers specified technology transfers and related transactions, including some arrangements already underway.
Businesses should review licensing agreements, research collaborations, ownership transfers and technical-support arrangements to determine whether additional registration or approval requirements apply. The precise obligations will depend on the technology, transaction and applicable Chinese regulations.
For companies in India and other markets, the proposal is also a reason to assess supply-chain concentration. Alternative technology partners, local research capacity and diversified sourcing can help reduce dependence on a single country, although developing advanced manufacturing capabilities can take time and substantial investment.
The Bigger Picture
China’s proposed export controls illustrate how technology has become an increasingly important part of international economic and national-security policy. AI models, advanced solar manufacturing methods and biotechnology platforms can create commercial value, but they can also influence defence capabilities, industrial competitiveness and access to critical infrastructure.
The proposal does not shut down all exports in these industries. Instead, it creates different levels of control over selected technologies, with some transfers proposed for prohibition and others requiring permission. The final impact will depend on the wording of the rules, their implementation and the ability of overseas businesses to develop alternatives or obtain licences.
Looking Ahead
The immediate next step is China’s public consultation, which remains open until November 15, 2026. Companies involved in technology transfers should track the final catalogue and any implementing guidance rather than assume that the proposed restrictions are already fully in force. The temporary registration requirements also make it important for exporters to assess transactions that may fall within the specified categories.
For India, the solar provisions are particularly relevant to efforts to build domestic manufacturing capacity. The longer-term outcome will depend on whether local investment, research partnerships and alternative sources of technical expertise can offset any barriers created by the new rules. For the global technology industry, the proposal is another reminder that access to advanced know-how may increasingly depend on geopolitics and export-control policy, not just commercial demand.
Frequently Asked Questions
1. What technologies is China proposing to restrict?
The draft covers 40 technologies: 23 in AI, 12 in solar photovoltaics and five in biotechnology. Fourteen are proposed for export prohibition, while 26 would face restrictions.
2. Is China banning all AI exports?
No. The proposal covers specified AI technologies, including some foundation-model, agent and computing capabilities. Most AI technologies would remain freely exportable, and publicly available technologies would generally be exempt.
3. Will China stop exporting solar panels to India?
The proposal is not a blanket ban on solar panels. It focuses on selected manufacturing technologies and technical transfers, including certain advanced solar-cell processes and polysilicon engineering capabilities.
4. Why could India’s solar industry be affected?
Indian companies may need access to foreign manufacturing know-how, licensing or technical support to develop advanced production capacity. Restrictions on selected Chinese technologies could make some transfers more difficult or require additional approvals.
5. When will the proposed restrictions become final?
Public consultation is open until November 15, 2026. The final requirements will depend on the revised catalogue and implementing rules issued by the Chinese authorities.
6. Does the proposal affect biotechnology products and medicines generally?
No. It targets specified biotechnology technologies and transfers, including selected cell and gene therapy platforms and siRNA-related technology. It is not a blanket ban on all medicines or biotechnology products.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
